| SKIP001108 | |
| SKIP ID | SKIP001108 |
| Organism(En) | - |
| Organism(Ja) | - |
| Cell Type(En) | - |
| Cell Type(Ja) | - |
| Cell Tissue(En) | - |
| Cell Tissue(Ja) | - |
| Cell Origin | Normal |
| Cell Name 1(En) | ctr-2 |
| Cell Name 1(Ja) | ctr-2 |
| Cell Name 2(En) | - |
| Cell Name 2(Ja) | - |
| Disease Name 1(Ja) | - |
| ICD Code 1 | - |
| Disease Name 1(En) | - |
| OMIM1 | - |
| Disease Name 2(Ja) | - |
| ICD Code 2 | - |
| Disease Name 2(En) | - |
| OMIM 2 | - |
| Disease Name 3(Ja) | - |
| ICD Code 3 | - |
| Disease Name 3(En) | - |
| OMIM 3 | - |
| Age | - |
| Age Range | -- |
| Sex | Unknown |
| Race(En) | - |
| Race(Ja) | - |
| Genetic Diagnosis | -- |
| Not Detected | No |
| Description(En) | sibling-of N296H |
| Description(Ja) | N296Hのきょうだい(影響を受けていない）由来iPS細胞 |
| Cell Morphology | human ES-like |
| Grade | Research Grade |
| Vector | Lentivirus |
| Transgene | OCT4, SOX2, c-MYC and KLF4. |
| Adhesiveness | Yes |
| Feeder | Yes |
| Feeder Cell | MEF |
| Medium | DMEM/F12 (1:1), 20% KOSR, 1% MEM non-essential amino acids, 100 ng/ml bFGF, 1 mM L-glutamine and 0.1 mM b-ME. |
| Genome Editing | - |
| CO2 | 0 |
| Mycoplasma | Unknown |
| Detection of Contaminants Mycoplasma | - |
| Pluripotent Markers | Yes |
| Pluripotent Markers Assay | Immunocytochemistry |
| in vitro Differentiation | Yes |
| in vitro Differentiation Assay | - |
| in vivo Differentiation | Yes |
| in vivo Differentiation Assay | teratoma analyses |
| Other 1 Assay | - |
| Other 1 Assay Method | - |
| Other 2 Assay | - |
| Other 2 Assay Method | - |
| Other 3 Assay | - |
| Other 3 Assay Method | - |
| Karyotype | Yes |
| Karyotype Assay | - |
| Remaining Vector Detection | No |
| Remaining Vector Detection Assay | - |
| STR | - |
| HLA | - |
| Stem Cell Transcriptome analysis | Yes |
| Stem Cell Transcriptome analysis Assay | sequencing analysis |
| Author Name(En) | Ruchira Singh |
| Author Name(Ja) | Ruchira Singh |
| Author Organization(En) | Waisman Center |
| Author Organization(Ja) | Waisman Center |
| Author Contact Email | dgamm[at]wisc[dot]edu |
| PI Organization(En) | Waisman Center |
| PI Organization(Ja) | Waisman Center |
| PI Name(En) | David M. Gamm |
| PI Name(Ja) | David M. Gamm |
| PI Contact Email | - |
| Availability | Information Only |
| Provider Organization(En) | - |
| Provider Organization(Ja) | - |
| Provider Email | - |
| Provider URL | - |
| Ethical Statement(En) | - |
| Ethical Statement(Ja) | - |
| Terms of Use(En) | - |
| Terms of Use(Ja) | - |
| PubMed ID | 23139242 |
| DOI | 10.1093/hmg/dds469 |
| Title | iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. |
| Authors | Singh R, Shen W, Kuai D, Martin JM, Guo X, Smith MA, Perez ET, Phillips MJ, Simonett JM, Wallace KA, Verhoeven AD, Capowski EE, Zhang X, Yin Y, Halbach PJ, Fishman GA, Wright LS, Pattnaik BR, Gamm DM |
| Journal | Hum Mol Genet |
| Year | 2012 |
| Volume | 22 |
| Issue | 3 |
| Pages | 593-607 |
| URL | - |
| Free input | - |
| Note | - |